UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2459) 2459
Newsletter (30) 30
Dissertation (27) 27
Book Chapter (21) 21
Publication (21) 21
Conference Proceeding (16) 16
Magazine Article (12) 12
Government Document (7) 7
Newspaper Article (4) 4
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1564) 1564
life sciences & biomedicine (1482) 1482
endostatin (1417) 1417
humans (1378) 1378
animals (1038) 1038
mice (726) 726
female (694) 694
male (648) 648
angiogenesis (620) 620
oncology (529) 529
biological and medical sciences (451) 451
endostatins (444) 444
medical sciences (397) 397
middle aged (352) 352
endostatins - genetics (337) 337
tumors (329) 329
vascular endothelial growth factor (327) 327
endostatins - metabolism (296) 296
aged (292) 292
adult (290) 290
endostatins - pharmacology (285) 285
cancer (251) 251
cell line, tumor (247) 247
biochemistry & molecular biology (241) 241
angiogenesis inhibitors - pharmacology (222) 222
endostatins - blood (219) 219
medicine, research & experimental (217) 217
research & experimental medicine (217) 217
angiogenesis inhibitors - therapeutic use (214) 214
research (203) 203
endostatins - therapeutic use (201) 201
gene therapy (196) 196
angiogenesis inhibitors (191) 191
mice, nude (180) 180
mice, inbred balb c (179) 179
cell biology (174) 174
endostatins - administration & dosage (171) 171
chemotherapy (167) 167
mice, inbred c57bl (167) 167
analysis (166) 166
care and treatment (161) 161
antineoplastic agents (160) 160
neovascularization, pathologic - drug therapy (158) 158
immunohistochemistry (156) 156
cells, cultured (155) 155
biotechnology & applied microbiology (150) 150
enzyme-linked immunosorbent assay (149) 149
antineoplastic agents - therapeutic use (147) 147
health aspects (146) 146
apoptosis (144) 144
neovascularization (141) 141
vascular endothelial growth factor a - metabolism (141) 141
rats (140) 140
pharmacology. drug treatments (139) 139
proteins (139) 139
angiostatin (135) 135
vegf (130) 130
peptide fragments - genetics (128) 128
collagen (127) 127
disease models, animal (126) 126
pharmacology & pharmacy (126) 126
genetic therapy (124) 124
recombinant human endostatin (124) 124
collagen type xviii (123) 123
gene expression (123) 123
collagen - genetics (122) 122
peptide fragments - therapeutic use (121) 121
lung cancer (120) 120
peptide fragments - pharmacology (118) 118
cardiovascular system (117) 117
neoplasm transplantation (117) 117
prognosis (115) 115
recombinant proteins - pharmacology (115) 115
antineoplastic agents - pharmacology (113) 113
neovascularization, pathologic (112) 112
physiological aspects (112) 112
cell proliferation (111) 111
collagen - therapeutic use (111) 111
blotting, western (110) 110
cell proliferation - drug effects (110) 110
tumor cells, cultured (110) 110
cell line (109) 109
genetic therapy - methods (109) 109
genetic vectors (109) 109
transfection (107) 107
metastasis (106) 106
collagen - pharmacology (103) 103
genetics & heredity (103) 103
xenograft model antitumor assays (103) 103
endothelial cells (101) 101
fundamental and applied biological sciences. psychology (99) 99
neovascularization, pathologic - pathology (99) 99
medicine (98) 98
medicine & public health (98) 98
abridged index medicus (97) 97
endostatins - biosynthesis (97) 97
vascular endothelial growth factors (97) 97
cell movement - drug effects (96) 96
angiogenesis inhibitors - genetics (95) 95
endothelium, vascular - cytology (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2376) 2376
Chinese (256) 256
Japanese (33) 33
French (19) 19
Russian (12) 12
Portuguese (11) 11
Persian (7) 7
Polish (6) 6
Korean (5) 5
German (4) 4
Dutch (2) 2
Italian (2) 2
Turkish (2) 2
Finnish (1) 1
Slovak (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


OncoTargets and therapy, ISSN 1178-6930, 10/2016, Volume 9, pp. 6727 - 6732
Ring formation | Esophageal cancer-associated lymphatic endothelial cells | VEGF-C | Proliferation | Esophageal squamous carcinoma cells | Oncology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Genetic aspects | Research | Vascular endothelial growth factor | Analysis | Esophageal cancer | Endothelium | Care and treatment | Squamous cell carcinoma | Development and progression | Gene expression | Health aspects | Diabetic retinopathy | Lymphatic system | Laboratories | Brain cancer | Metastasis | Kinases | Design | Angiogenesis | Plasmids | Fibroblasts | Diabetes | Prostate | the alive cells quantity in blank control group were the largest | Endostatin group was for the esophageal cancer cells conditional medium of optimum concentration endostatin processed | SG1 plus endostatin group and SG2 plus endostatin group. There was no statistical significance between the comparison of SG1 group and SG2 group | SG1 group | SG1 plus endostatin group and SG2 plus endostatin group (P >0.05). The comparison between rest groups had statistical significance (P | negative plus endostatin group | the three dimensional culture results of negative control group was the highest | of which were the negative plus endostatin group | SG2 group was for the conditional medium of SG2 plasmid transfected esophageal cancer cells | then followed by blank control group | endostatin group | Negative control group was for the conditional medium of empty plasmid transfected esophageal cancer cells | Objective To investigate the effects of VEGF-C inRNA eukaryotic expression vector and expression of endostatin on esophageal squamous carcinoma-related ring formation in vitro and proliferation of lymphatic endothelial cells. Methods KYSE150 cells were subjected to analysis of cell transfection and endostatin operation. The conditional medium was prepared as well. Blank control group was for the conditional medium of esophageal cancer cells without transfection | negative plus endostatin group did not have statistical significance (P>0.05) | SG1 group and negative plus endostatin group | SG1 plus endostatin group and SG2 plus endostatin group. The esophageal cancer related microlymphatic endothelial cells were three-dimensional cultured and was calculated for the various cells formed tube-like structures. CCK-8 assay was employed to detect the cell proliferation condition. Result Generally comparison | SG2 plus endostatin group. The comparsion between SG1 plus endostatin group and SG2 endostatin group did not have statistical significance (P>0.05) | SG2 group and endostation group | SG2 group and negative plus endostatin group | There were also additional three groups | SG2 group | SG1 group was for the conditional medium of SG1 plasmid transfected with esophageal cancer cells | SG1 group and endostation group | the comparison between rest groups had statistical significance (P | then followed by negative control group | the comparsion between every two of SG1 group | SG1 plus endostatin group
Journal Article
Tumor biology, ISSN 1010-4283, 7/2017, Volume 39, Issue 7, pp. 1 - 9
Angiogenesis | Vascular normalization | Recombinant human endostatin | Anterior gradient 2 | Gold nanoparticles | Life Sciences & Biomedicine | Oncology | Science & Technology | Gold - administration & dosage | Colorectal Neoplasms - genetics | Humans | Endostatins - chemistry | Neovascularization, Pathologic - pathology | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Heterografts | Colorectal Neoplasms - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Gold - chemistry | Human Umbilical Vein Endothelial Cells - drug effects | Neoplasm Proteins - biosynthesis | Metal Nanoparticles - chemistry | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | Recombinant Proteins - administration & dosage | Endostatins - genetics | Proteins - genetics | Cell Movement - drug effects | Animals | Metal Nanoparticles - administration & dosage | Neovascularization, Pathologic - drug therapy | Endostatins - administration & dosage | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Mice | Colorectal Neoplasms - pathology | Angiogenesis Inhibitors - chemistry | Phosphorylation | Authorship | Colorectal carcinoma | Colorectal cancer | Endostatin | Metastasis | Cancer therapies | Metastases | Nanoparticles | Xenografts | Vascular endothelial growth factor receptor 2 | Vascular endothelial growth factor | Gold | Extracellular signal-regulated kinase | FDA approval | Cadherin | Endothelial cells | Gelatinase A | Studies | Chemotherapy | Morphology | Hypoxia | Laboratory animals | Umbilical vein | Cell migration | Tumors | Index Medicus
Journal Article
Biological & pharmaceutical bulletin, ISSN 0918-6158, 2011, Volume 34, Issue 4, pp. 545 - 550
Journal Article
Journal Article
Journal Article
Journal Article